The real question hanging over all this is whether there was a quid pro quo for Mr. Chen’s release.

The only leverage the U.S. had was to cancel the summit as soon as it learned that China was going back on its word.

The past two weeks of turmoil and drama in Sino-American affairs may well be the new normal, not an exception to an otherwise placid bilateral relationship. While Friday brought news of a possible deal allowing dissident Chen Guangcheng to leave China to study in America, that deal is no more certain than the earlier, failed deal, announced just days before

The Obama administration is going all out to attract Chinese companies to invest in the U.S., but at the same time, it has rebuffed the efforts of the Chinese telecoms giant Huawei to obtain contracts with major U.S. Internet providers or to take over U.S. telecom companies. At this event, a panel of experts will analyze the issues from both an economic and a security perspective.

As China grows less predictable and the United States less willing to shoulder its responsibilities, familiar patterns of bilateral relations must change.

Knowing where all our ingredients come from is the first step toward improving drug quality.

While Bo's story is about power, it should not obscure the fact that there is an ideological struggle going on inside China.